A new release of FactoryTalk Batch software from Rockwell Automation eases recipe creation and adds security.
The latest release of FactoryTalk Batch software from Rockwell Automation eases the process of modifying and creating new recipes by managing the approval process for changes and automatically tracking the genealogy of recipes. New security-authority binding features also help manufacturers protect their intellectual property. The FactoryTalk Batch v12.0 software is now available as part of the PlantPAx process automation system from Rockwell Automation.
The upgraded software provides solutions ranging from small, basic sequencing to large, complex batch and sequencing applications. Administrators can use the software to assign specific people or roles to approve recipes before they advance to the production line. This structured approach provides approval traceability and allows quality control managers to easily manage recipes.
With new version-control capabilities, the software preserves and locks recipes from changes. Later, the recipe can be checked out as a work in progress and is automatically assigned a new version. The updated software system automatically stores each version, allowing users to review their genealogy. Recipe authors can manage more recipes and save time previously spent manually backing up files for each recipe change.
FactoryTalk Batch software also provides additional protection from intellectual property theft. With security-authority binding, the software helps protect recipes and area models. This extra layer of security helps ensure that important information is inaccessible for viewing, editing or executing by unauthorized users.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.